Navigation Links
Blood Protein Might Signal Death Risk in Elderly
Date:8/30/2011

By Amanda Gardner
HealthDay Reporter

TUESDAY, Aug. 30 (HealthDay News) -- Swedish scientists have identified a protein circulating in the blood which seems to be a harbinger of an increased risk of death among elderly people.

The protein, cathepsin S, is strongly tied to the inflammatory processes that are central to killers such as cancer and heart disease.

The authors of the new study, published online Aug. 30 in the Journal of the American Medical Association and simultaneously being presented at the European Society of Cardiology Congress in Paris, suggest that the protein might be a target for drugs, some of which are already being tested in trials.

In theory, such a biomarker could also "help us interpret how to direct health care," said Thomas Mariani, an associate professor of pediatrics, medicine and environmental medicine at the University of Rochester Medical Center.

But widespread use of the marker is still a ways away, Mariani added.

Previous studies have found higher levels of cathepsin S, an enzyme, in patients who are obese or who have diabetes or heart disease. Patients who lose weight reportedly have lower levels of cathepsin S.

Researchers have speculated that the protein may be involved in the development of atherosclerosis. It may also cause cancer tumors to develop and spread.

The authors of the study, from Uppsala University in Sweden, correlated cathepsin S levels with mortality in two groups of elderly people.

The first group consisted of 1,000 men in Uppsala with an average age of 71 who were followed for an average of 13 years.

The second group also consisted of 1,000 people of about the same age, this time half women and half men. They were followed for about eight years.

Even after adjusting for factors such as age, blood pressure, diabetes, smoking, weight, cholesterol levels and history of heart disease, men in the first group who
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Poor Sleep, High Blood Pressure?
2. New Blood Thinner May Outperform Warfarin for Irregular Heartbeat
3. Stanford researchers invent sutureless method for joining blood vessels
4. C-Sections Linked to Doubled Risk for Blood Clots
5. FDA clears new IMMY and University of Nevada, Reno life-saving blood test
6. Common vein condition increases risk for developing life-threating blood clots
7. Blood Antibody May Signal Start of Ovarian Cancer
8. Central Catheters May Raise Risk of Blood Clots After Surgery
9. Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat
10. Study finds popular muscle-boosting supplement does not increase blood flow
11. Maternal Blood Test Can Determine Sex of Fetus at 7 Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Protein Might Signal Death Risk in Elderly
(Date:9/19/2014)... 19, 2014) Shahram Majidi, M.D., a second-year ... George Washington University School of Medicine and Health ... Heart Association to study the presence of diffuse ... hemorrhage (ICH). , "According to epidemiological studies, intracerebral ... all strokes, but is the least treatable form ...
(Date:9/19/2014)... and large protein complexes are notoriously difficult to study ... very difficult, if not impossible, to crystallize, but also ... The result is that when a structure can be ... reveals a mosaic-like spread of protein domains that sometimes ... Brunger. (2014), Acta Cryst . D70, 2241-2255; ...
(Date:9/19/2014)... 19, 2014 BCC Research reveals in ... GLOBAL MARKETS , the global market for human antifungal ... by 2018, with a five-year compound annual growth rate ... growing at a steady 3.8% CAGR. , Given the ... sales, coupled with the incidence of increasing mortality and ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Capital ... Reed Ference, is excited to announce the latest ... periodontal disease, gingivitis and those needing dental implants. ... LANAP® laser treatment removes the fear factor normally ... stitches, less discomfort and bleeding make, this procedure ...
(Date:9/19/2014)... Singulair, developed by Merck, is a CysLT1 ... (LTD4). LTD4 belongs to the family of Cys-LTs, which ... mast cells and eosinophils, and which bind to the ... there are higher concentrations of Cys-LTs in the airways ... production of CysLTs is increased in asthmatics, particularly during ...
Breaking Medicine News(10 mins):Health News:GW researcher receives grant to study brain swelling following bleeding in the brain 2Health News:A refined approach to proteins at low resolution 2Health News:A refined approach to proteins at low resolution 3Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 2Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4
... disease (COPD) are more likely to suffer worse consequences ... due to be presented at the American Thoracic Society ... play a role in the increased death rate seen ... M.D., Assistant Professor of Medicine at the University of ...
... as many patients in the chronic disease management programs ... Boon Wan who was addressing he third National Disease ... of death and human suffering remains a fact as ... could be an effective tool in such circumstances. To ...
... socioeconomic status have a higher level of stress hormones in ... the newest issue of Psycosomatic Medicine, this increased level is ... study does not have to do with poverty, per se,’ ... Carnegie Mellon University. He said the purpose of the study ...
... the popular belief that the effect of war and ... soldier’s partner and children//. It highlights that war trauma ... ,Psychiatrist Arend Veeninga, in the Dutch monthly ... to the theory that ‘war trauma is infectious’. ...
... Researchers at Baylor University Medical Center at Dallas and ... to introduce insulin genes into the pancreas//. , ... (blood sugar) to enter the cells of the body ... ultrasound-targeted micro bubble destruction (UTMD), delivers these insulin genes ...
... the Internet, cancer patients find it hard to locate ... new study has found. Surprisingly, most cancer patients seek ... cancer information on their own, reveals the study conducted ... ,Despite the ease and availability of Internet ...
Cached Medicine News:Health News:Lung Disease More Severe In Women Than Men 2Health News:Lung Disease More Severe In Women Than Men 3Health News:Hormone Levels Increase Due To Socioeconomic Stress 2Health News:Bubble Technique on the cards For Treatment of Type I diabetes 2Health News:Internet Searches Fail To Give Useful Information To Cancer Patients 2
(Date:9/19/2014)... 2014  CytRx Corporation (Nasdaq: CYTR ), ... today announced that David J. Haen , Vice ... in the Biotech Industry Conference on Friday, September 26 th ... take place at the Millennium Broadway Hotel in ... live and archived webcast of the presentation will be ...
(Date:9/19/2014)... PHILADELPHIA , Sept. 19, 2014  PCI ... Services International (Biotec).  Biotec is a leading provider ... Services headquartered in Bridgend, Wales ... .  The addition significantly expands PCI,s presence in ... medicinal products by adding packaging, storage and distribution ...
(Date:9/18/2014)... Sept. 18, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... exercise of the underwriters, option to purchase 675,000 ... the company,s previously announced public offering of 4,500,000 ... are being offered by Aratana Therapeutics.  With the ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2
... U.S. Food and Drug Administration (FDA) approved ... of INTELENCE ® (etravirine), a non-nucleoside reverse transcriptase ... virus (HIV-1) in treatment-experienced adults with resistance to an ... The recommended oral dose of INTELENCE tablets is 200 ...
... KONG, Jan. 3, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech ... with its subsidiary collectively as the "Group" - 801.HK), ... announce that the Company has obtained the approvals from ... Futures Bureau for its proposed offering and listing of ...
Cached Medicine Technology:FDA Approves New Dosage Strength for INTELENCE® 2FDA Approves New Dosage Strength for INTELENCE® 3FDA Approves New Dosage Strength for INTELENCE® 4FDA Approves New Dosage Strength for INTELENCE® 5Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Medicine Products: